Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-12

AUTHORS

Jazmin Duque, Meredith L McMorrow, Adam L Cohen

ABSTRACT

BACKGROUND: Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa. METHODS: A self-administered survey was distributed among key influenza experts in 40 African countries. RESULTS: Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population. CONCLUSIONS: Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely. More... »

PAGES

41

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2458-14-41

DOI

http://dx.doi.org/10.1186/1471-2458-14-41

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010477963

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24433304


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Africa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Centers for Disease Control and Prevention", 
          "id": "https://www.grid.ac/institutes/grid.416738.f", 
          "name": [
            "International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, 30333, Atlanta, GA, USA", 
            "Battelle Atlanta, 2987 Clairmont NE Suite 450, 30329, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Duque", 
        "givenName": "Jazmin", 
        "id": "sg:person.01023072061.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023072061.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "United States Public Health Service", 
          "id": "https://www.grid.ac/institutes/grid.417684.8", 
          "name": [
            "International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, 30333, Atlanta, GA, USA", 
            "U.S. Public Health Service, Rockville, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McMorrow", 
        "givenName": "Meredith L", 
        "id": "sg:person.0751351640.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751351640.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "United States Public Health Service", 
          "id": "https://www.grid.ac/institutes/grid.417684.8", 
          "name": [
            "International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, 30333, Atlanta, GA, USA", 
            "U.S. Public Health Service, Rockville, MD, USA", 
            "Influenza Program, U.S. Centers for Disease Control and Prevention-South Africa, PO Box 9536, Pretoria 0001, South Africa"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cohen", 
        "givenName": "Adam L", 
        "id": "sg:person.01361324704.64", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361324704.64"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1473-3099(11)70008-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003570850"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis530", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003679364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0024579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003712929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007011322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2012.10.111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011240049"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2006.07.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011879796"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)61051-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015411371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2011.10.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019705412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020734554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2010.11.029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032081990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0052842", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033240101"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1473-3099(12)70121-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037414138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046184919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jis548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050742128"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/657314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052516758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5365/wpsar.2013.4.1.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072793468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075198058", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075273156", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077680010", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "BACKGROUND: Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa.\nMETHODS: A self-administered survey was distributed among key influenza experts in 40 African countries.\nRESULTS: Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population.\nCONCLUSIONS: Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2458-14-41", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024954", 
        "issn": [
          "1471-2458"
        ], 
        "name": "BMC Public Health", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?", 
    "pagination": "41", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "31eacfd89ed04b12098e8eed634e9a0438dd2845bb63719999417ec3398193a1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24433304"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2458-14-41"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010477963"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2458-14-41", 
      "https://app.dimensions.ai/details/publication/pub.1010477963"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_54011_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2458-14-41"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-14-41'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-14-41'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-14-41'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2458-14-41'


 

This table displays all metadata directly associated to this object as RDF triples.

170 TRIPLES      21 PREDICATES      55 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2458-14-41 schema:about N053ae2a14b9b4baa8fcd4c6c7985f4c5
2 N0dce1ae5e8e14e328827178894557184
3 N3a3c8675f2984f03a8ad591994f3f3f6
4 N7b7278c8ac7043869e5959c5f360660e
5 N81af01f1f62346c882c3b3071291b7ea
6 N85a59a08c5b44526a3c32b88135e4efc
7 Ne072f2411632490a9836c85ebf795f2b
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author N1198900ee5c64781b404df06d2cd40da
11 schema:citation https://app.dimensions.ai/details/publication/pub.1075198058
12 https://app.dimensions.ai/details/publication/pub.1075273156
13 https://app.dimensions.ai/details/publication/pub.1077680010
14 https://doi.org/10.1016/j.vaccine.2006.07.021
15 https://doi.org/10.1016/j.vaccine.2010.11.029
16 https://doi.org/10.1016/j.vaccine.2011.10.030
17 https://doi.org/10.1016/j.vaccine.2012.10.111
18 https://doi.org/10.1016/s0140-6736(11)61051-9
19 https://doi.org/10.1016/s1473-3099(11)70008-1
20 https://doi.org/10.1016/s1473-3099(12)70121-4
21 https://doi.org/10.1086/657314
22 https://doi.org/10.1093/infdis/jis530
23 https://doi.org/10.1093/infdis/jis548
24 https://doi.org/10.1093/infdis/jis575
25 https://doi.org/10.1093/infdis/jis599
26 https://doi.org/10.1093/infdis/jis606
27 https://doi.org/10.1371/journal.pone.0024579
28 https://doi.org/10.1371/journal.pone.0052842
29 https://doi.org/10.5365/wpsar.2013.4.1.009
30 schema:datePublished 2014-12
31 schema:datePublishedReg 2014-12-01
32 schema:description BACKGROUND: Influenza viruses cause significant morbidity and mortality in Africa, particularly among high-risk groups, but influenza vaccines and antiviral drugs may not be commonly available and used. The main aim of this study was to determine the availability and use of influenza vaccines and antiviral drugs as well as to describe existing related guidelines and policies in Africa. METHODS: A self-administered survey was distributed among key influenza experts in 40 African countries. RESULTS: Of the 40 countries surveyed, 31 (78%) responded; 14/31 (45%) reported availability of seasonal influenza vaccine, and 19/31 (65%) reported availability of antiviral drugs for the treatment of influenza. Vaccine coverage data were only available for 4/14 (29%) countries that reported availability of seasonal influenza vaccine and ranged from <0.5% to 2% of the population. CONCLUSIONS: Influenza vaccines and antiviral drugs are available in many countries in Africa but coverage estimates are low and remain largely unknown. Describing the local burden of disease and identifying funding are essential to encourage countries to use influenza vaccine more widely.
33 schema:genre research_article
34 schema:inLanguage en
35 schema:isAccessibleForFree true
36 schema:isPartOf N21f7416d283947efaea32402c0a572e7
37 Ndced573275e0405baed341378165957f
38 sg:journal.1024954
39 schema:name Influenza vaccines and influenza antiviral drugs in Africa: are they available and do guidelines for their use exist?
40 schema:pagination 41
41 schema:productId N191ee6663d2f426f8bf8379c9f82b3d3
42 N83563b849aeb468192ae3b108d44e698
43 Na1840b3974d34f6297b4dcdb9ecc0152
44 Nf6bc4ec39b8f449c9ec1aa4b13e415a0
45 Nfa0a3e8e80544a919cb46baf8eb0c244
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010477963
47 https://doi.org/10.1186/1471-2458-14-41
48 schema:sdDatePublished 2019-04-11T12:15
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher N33fdf1975b0c426998ca3a72573eeb1c
51 schema:url http://link.springer.com/10.1186%2F1471-2458-14-41
52 sgo:license sg:explorer/license/
53 sgo:sdDataset articles
54 rdf:type schema:ScholarlyArticle
55 N053ae2a14b9b4baa8fcd4c6c7985f4c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Humans
57 rdf:type schema:DefinedTerm
58 N0dce1ae5e8e14e328827178894557184 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Africa
60 rdf:type schema:DefinedTerm
61 N1198900ee5c64781b404df06d2cd40da rdf:first sg:person.01023072061.72
62 rdf:rest N922f9f51a6d94b298dd042de18701dee
63 N191ee6663d2f426f8bf8379c9f82b3d3 schema:name doi
64 schema:value 10.1186/1471-2458-14-41
65 rdf:type schema:PropertyValue
66 N21f7416d283947efaea32402c0a572e7 schema:issueNumber 1
67 rdf:type schema:PublicationIssue
68 N33fdf1975b0c426998ca3a72573eeb1c schema:name Springer Nature - SN SciGraph project
69 rdf:type schema:Organization
70 N3a3c8675f2984f03a8ad591994f3f3f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Influenza Vaccines
72 rdf:type schema:DefinedTerm
73 N7b7278c8ac7043869e5959c5f360660e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Surveys and Questionnaires
75 rdf:type schema:DefinedTerm
76 N81af01f1f62346c882c3b3071291b7ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Influenza, Human
78 rdf:type schema:DefinedTerm
79 N83563b849aeb468192ae3b108d44e698 schema:name dimensions_id
80 schema:value pub.1010477963
81 rdf:type schema:PropertyValue
82 N85a59a08c5b44526a3c32b88135e4efc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Antiviral Agents
84 rdf:type schema:DefinedTerm
85 N922f9f51a6d94b298dd042de18701dee rdf:first sg:person.0751351640.51
86 rdf:rest Nfa0fc6cf070f4e94bcf9cf0a763cb3fb
87 Na1840b3974d34f6297b4dcdb9ecc0152 schema:name pubmed_id
88 schema:value 24433304
89 rdf:type schema:PropertyValue
90 Ndced573275e0405baed341378165957f schema:volumeNumber 14
91 rdf:type schema:PublicationVolume
92 Ne072f2411632490a9836c85ebf795f2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Guidelines as Topic
94 rdf:type schema:DefinedTerm
95 Nf6bc4ec39b8f449c9ec1aa4b13e415a0 schema:name nlm_unique_id
96 schema:value 100968562
97 rdf:type schema:PropertyValue
98 Nfa0a3e8e80544a919cb46baf8eb0c244 schema:name readcube_id
99 schema:value 31eacfd89ed04b12098e8eed634e9a0438dd2845bb63719999417ec3398193a1
100 rdf:type schema:PropertyValue
101 Nfa0fc6cf070f4e94bcf9cf0a763cb3fb rdf:first sg:person.01361324704.64
102 rdf:rest rdf:nil
103 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
104 schema:name Medical and Health Sciences
105 rdf:type schema:DefinedTerm
106 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
107 schema:name Clinical Sciences
108 rdf:type schema:DefinedTerm
109 sg:journal.1024954 schema:issn 1471-2458
110 schema:name BMC Public Health
111 rdf:type schema:Periodical
112 sg:person.01023072061.72 schema:affiliation https://www.grid.ac/institutes/grid.416738.f
113 schema:familyName Duque
114 schema:givenName Jazmin
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023072061.72
116 rdf:type schema:Person
117 sg:person.01361324704.64 schema:affiliation https://www.grid.ac/institutes/grid.417684.8
118 schema:familyName Cohen
119 schema:givenName Adam L
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361324704.64
121 rdf:type schema:Person
122 sg:person.0751351640.51 schema:affiliation https://www.grid.ac/institutes/grid.417684.8
123 schema:familyName McMorrow
124 schema:givenName Meredith L
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751351640.51
126 rdf:type schema:Person
127 https://app.dimensions.ai/details/publication/pub.1075198058 schema:CreativeWork
128 https://app.dimensions.ai/details/publication/pub.1075273156 schema:CreativeWork
129 https://app.dimensions.ai/details/publication/pub.1077680010 schema:CreativeWork
130 https://doi.org/10.1016/j.vaccine.2006.07.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011879796
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1016/j.vaccine.2010.11.029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032081990
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1016/j.vaccine.2011.10.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019705412
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1016/j.vaccine.2012.10.111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011240049
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1016/s0140-6736(11)61051-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015411371
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/s1473-3099(11)70008-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003570850
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/s1473-3099(12)70121-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037414138
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1086/657314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052516758
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1093/infdis/jis530 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003679364
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1093/infdis/jis548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050742128
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1093/infdis/jis575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007011322
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1093/infdis/jis599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020734554
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1093/infdis/jis606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046184919
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1371/journal.pone.0024579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003712929
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1371/journal.pone.0052842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033240101
159 rdf:type schema:CreativeWork
160 https://doi.org/10.5365/wpsar.2013.4.1.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072793468
161 rdf:type schema:CreativeWork
162 https://www.grid.ac/institutes/grid.416738.f schema:alternateName Centers for Disease Control and Prevention
163 schema:name Battelle Atlanta, 2987 Clairmont NE Suite 450, 30329, Atlanta, GA, USA
164 International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, 30333, Atlanta, GA, USA
165 rdf:type schema:Organization
166 https://www.grid.ac/institutes/grid.417684.8 schema:alternateName United States Public Health Service
167 schema:name Influenza Program, U.S. Centers for Disease Control and Prevention-South Africa, PO Box 9536, Pretoria 0001, South Africa
168 International Epidemiology and Research Team, Epidemiology Branch, Influenza Division, U.S. Centers for Disease Control and Prevention, 1600 Clifton Rd NE MS-A32, 30333, Atlanta, GA, USA
169 U.S. Public Health Service, Rockville, MD, USA
170 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...